Christopher Durant Turner

NUVL

Christopher Durant Turner serves as officer: Chief Medical Officer at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$2.19M

Net Position

Net Seller

$2.19M

Companies Traded

NUVL

Active Period

Jun 2023 – Jan 2026

6 total trades

Most Recent

Sell NUVL

Jan 7, 2026 · $721.3K

Christopher Durant Turner's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

0 · $0.00

Sells

6 · $2.19M

Total Shares Bought

Total Shares Sold

34,993

NUVL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2026	Sell	7,417	$97.25	$721.3K	61,676
Jan 8, 2025	Sell	4,016	$79.68	$320.0K	65,411
Oct 6, 2023	Sell	7,995	$54.04	$432.0K	19,843
Jul 28, 2023	Sell	5,030	$47.95	$241.2K	14,513
Jul 24, 2023	Sell	300	$46.81	$14.0K	14,513
Jun 7, 2023	Sell	10,235	$44.86	$459.1K	14,513